Prostate Cancer - Results from #28000

The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer - Abstract June 6, 2011

Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease - Abstract June 6, 2011

Statin use and risk of prostate cancer in a population of men who underwent biopsy - Abstract June 6, 2011

Advancements in MR imaging of the prostate: From diagnosis to interventions - Abstract June 6, 2011

Role of neuroendocrine cells in prostate cancer progression - Abstract June 6, 2011

Data presented at the 47th American Society of Clinical Oncology (ASCO) annual meeting demonstrate the potential of circulating tumor cells (CTC) as a biomarker for metastatic prostate cancer clinical trials June 6, 2011

Editor's Commentary - The genomic complexity of primary human prostate cancer June 6, 2011

Effect of age, family history of prostate cancer, prostate enlargement and seasonality on PSA levels in a contemporary cohort of healthy Italian subjects - Abstract June 5, 2011

Parameters to improve the specificity of the prostate-specific antigen: Early detection of prostate cancer - Abstract June 4, 2011

The role of lymph node dissection in the management of prostate cancer - Abstract June 3, 2011

Radiation therapy and androgen deprivation in the management of high risk prostate cancer - Abstract June 3, 2011

National Cancer Institute Prostate Cancer Genetics Workshop - Abstract June 3, 2011

Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen dependent prostate cancer - Abstract June 3, 2011

Andropause syndrome in men treated for metastatic prostate cancer: A qualitative study of the impact of symptoms - Abstract June 3, 2011

Continuous vs. intermittent androgen deprivation therapy for metastatic prostate cancer - Abstract June 3, 2011

The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series - Abstract June 3, 2011

Quantification of extraprostatic perineural spread and its prognostic value in pT3a pN0 M0 R0 prostate cancer patients - Abstract June 3, 2011

Assessing muscle function of the male pelvic floor using real time ultrasound - Abstract June 3, 2011

Pathways of chemotherapy resistance in castration-resistant prostate cancer - Abstract June 3, 2011

Editor's Commentary - High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy June 3, 2011

Page 1401 of 1447